About

Committed To A World Of Healthy Brains and Minds

Perhaps the most impactful global health crisis of our lifetime is brain and mind health; from Alzheimer’s disease and other forms of cognitive impairment to mental health challenges affecting lives and societies around the world.

The inconsistency in diagnosing and treating patients with cognitive impairment in a clear and timely way compelled Neuro-Radiologist Dr. Emer MacSweeney, CEO, and healthcare business leader Tom Dent, Executive Chairman, to launch Re:Cognition Health. They believed a multi-disciplinary team providing the right clinical pathway to diagnose cognitive impairment was essential; along with the importance of providing hope, by making available the new and emerging international clinical drug trials in a supportive, compassionate and convenient environment.

Re:Cognition Health opened its first clinic in London in 2011 and quickly became an acknowledged leader in brain and mind health. Today, the company is comprised of transatlantic teams of passionate and caring experts, delivering hope, and brain and mind healthcare at the very highest level.

Re:Cognition Health operates an expanding network of leading specialised clinical trial centres collaborating with leading global pharmaceutical research companies with the commitment to being part of creating a world of healthy brains and minds through delivering successful trials of new disease-modifying molecules and treatments for all forms of cognitive impairment.